Cargando…
SPAG5 upregulation predicts poor prognosis in cervical cancer patients and alters sensitivity to taxol treatment via the mTOR signaling pathway
Autores principales: | Yuan, L-J, Li, J-D, Zhang, L, Wang, J-H, Wan, T, Zhou, Y, Tu, H, Yun, J-P, Luo, R-Z, Jia, W-H, Zheng, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669841/ https://www.ncbi.nlm.nih.gov/pubmed/26068792 http://dx.doi.org/10.1038/cddis.2015.163 |
Ejemplares similares
-
SPAG5 upregulation predicts poor prognosis in cervical cancer patients and alters sensitivity to taxol treatment via the mTOR signaling pathway
por: Yuan, L-J, et al.
Publicado: (2014) -
SPAG5‐AS1 inhibited autophagy and aggravated apoptosis of podocytes via SPAG5/AKT/mTOR pathway
por: Xu, Jun, et al.
Publicado: (2020) -
SPAG9 expression is increased in human prostate cancer and promotes cell motility, invasion and angiogenesis in vitro
por: Chen, Feifei, et al.
Publicado: (2022) -
Low-affinity neurotrophin receptor p75 of brain-derived neurotrophic factor contributes to cancer-induced bone pain by upregulating mTOR signaling
por: Meng, Xiao-Wen, et al.
Publicado: (2020) -
β-Hydroxyisovaleryl-shikonin induces human cervical cancer cell apoptosis via PI3K/AKT/mTOR signaling
por: Lu, Dan, et al.
Publicado: (2021)